GWTG Stroke PMT (Standard and Coverdell) Crosswalk with MSRT PMT Data Element Name MSRT Data Element Name
Final clinical diagnosis related to stroke
Final hospital diagnosis related to stroke that was ultimately responsible for this admission
When is the earliest documentation of comfort measures only?
When is the earliest documented time that patient was on CMO?
ARRIVAL AND ADMISSION INFORMATION
During this hospital stay, was the patient enrolled in a clinical trial in which patients
Was this patient in a stroke-related clinical trial?
with the same condition as the measure set were being studied?
Was this patient admitted for the sole purpose of performance of elective carotid
Elective Carotid intervention the sole purpose for admission?
Patient location when stroke symptoms discovered
Was the patient an ED patient at the facility?
Where patient first received care at your hospital
If not admitted to this hospital, where was patient transferred/ released?
Where was the patient cared for and by whom? Admission type
Where was the patient cared for and by whom? Stroke Consult
Consult type (Where patient care occurred)
Where was the patient cared for and by whom? Unit Location
DEMOGRAPHICS MEDICAL HISTORY
Currently pregnant or within 6 weeks postpartum
Currently pregnant or within 6 weeks postpartum
X=Needs to be bolded in the CRJC=Only in Joint Commission Overlay#=Outcome needs to add to Coverdell Overlay
Effective for discharges 10/1/10 and later
@=Abstract for cases discharged prior to 10/1/10
GWTG Stroke PMT (Standard and Coverdell) Crosswalk with MSRT PMT Data Element Name MSRT Data Element Name
Documented past medical history of smoking (patient smoked at least one cigarette during the prior year)?
Ambulatory status prior to current event?
Ambulation status prior to the current event
DIAGNOSIS & EVALUATION
Symptom duration if diagnosis of transient ischemic attack (<24 hours)
Weakness or paresis (Initial Exam Findings)
Initial exam findings: Altered level of consciousness
Level of consciousness (Initial Exam Findings)
Had stroke symptoms resolved at time of presentation?
Stroke symptoms resolve prior to presentation?
If Yes (NIHSS) - Actual, Estimated, or ND
First Glasgow Coma Scale (GCS) in ICH patients
MEDICATIONS PRIOR TO ADMISSION
Antithrombotic medications (antiplatelet or anticoagulant)
Antithrombotic medications (antiplatelet or anticoagulant) prior toadmission
Cholesterol reducing/ controlling medication
SYMPTOM TIMELINE
Time of Discovery same as Last Known Well
BRAIN IMAGING
Brain imaging completed at your hospital for this episode of care?
Was brain imaging performed at your hospital after arrival as part of the initial evaluation for this episode of care or this event?
Interpretation of first brain image after symptom onset, done at any facility
IV THROMBOLYTIC THERAPY
X=Needs to be bolded in the CRJC=Only in Joint Commission Overlay#=Outcome needs to add to Coverdell Overlay
Effective for discharges 10/1/10 and later
@=Abstract for cases discharged prior to 10/1/10
GWTG Stroke PMT (Standard and Coverdell) Crosswalk with MSRT PMT Data Element Name MSRT Data Element Name
Documented contraindications or warnings for not initiating IV thrombolytic in the 0-
Documented contraindications or warnings for not initiating IV thrombolytic in the 3-
Unable to diagnose or did not diagnose in 3 hour time frame
WAS OTHER THROMBOLYTIC/REPERFUSION THERAPY ADMINISTERED?
Was IV-tPA initiated at an outside hospital?
IA catheter-based reperfusion at this hospital?
Was IA catheter based reperfusion initiated at this hospital?
IA catheter-based reperfusion at outside hospital?
Was IA catheter based reperfusion initiated at outside hospital?
Investigational or experimental protocol for thrombolysis?
Investigational or experimental protocol for thrombolysis
Specify the investigational or experimental protocol for thrombolysis
IN-HOSPITAL TREATMENT AND COMPLICATIONS
Symptomatic intracranial hemorrhage within 36 hours of tPA
Symptomatic intracranial hemorrhage within 36 hours of tPA
Life-threatening, serious systemic hemorrhage within 36 hours of tPA
Life-threatening, serious systemic hemorrhage within 36 hours of tPA
If bleeding complications occur in patient transferred after IV-tPA
Patient NPO throughout the entire hospital stay?
No oral intake of medications, fluids, food throughout the entire hospital stay
Was patient screened for dysphagia prior to any oral intake including water or
Was patient screened for dysphagia prior to any oral intake,
Treatment for Hospital- Acquired Pneumonia
Was there documentation that the patient was treated for hospital acquired pneumonia (pneumonia not present on admission) during this admission?
Was patient ambulating at the end of hospital day 2?
Was patient ambulating the day of admission or the day after admission?
X=Needs to be bolded in the CRJC=Only in Joint Commission Overlay#=Outcome needs to add to Coverdell Overlay
Effective for discharges 10/1/10 and later
@=Abstract for cases discharged prior to 10/1/10
GWTG Stroke PMT (Standard and Coverdell) Crosswalk with MSRT PMT Data Element Name MSRT Data Element Name
Was DVT prophylaxis initiated by the end of hospital day 2?
Is there documentation why prophylaxis was not administered at hospital
Intermittent pneumatic compression devices (IPC)
Was graduated compression stockings provided to the patient?
What date was the initial VTE prophylaxis administered?
What date was the initial VTE prophylaxis administered?
Did patient experience a DVT or pulmonary embolus (PE) duringthe admission?
Was antithrombotic therapy administered by the end of hospital day 2?
Is there documentation by a physician/advanced practice nurse/physician assistant
or pharmacist in the medical record of a reason for not administering antithrombotic therapy by end of hospital day 2?
Was patient treated for a urinary tract infection (UTI) during this admission?
Was the patient treated for a urinary tract infection (UTI) during this admission?
If patient was treated for a UTI, did the patient have a Foley catheter during this
If patient was treated for a UTI, did the patient have a Foley
MEASUREMENTS
X=Needs to be bolded in the CRJC=Only in Joint Commission Overlay#=Outcome needs to add to Coverdell Overlay
Effective for discharges 10/1/10 and later
@=Abstract for cases discharged prior to 10/1/10
GWTG Stroke PMT (Standard and Coverdell) Crosswalk with MSRT PMT Data Element Name MSRT Data Element Name DISCHARGE INFORMATION
GWTG Ischemic Stroke-Only Estimated Mortality Rate
GWTG Global Stroke Estimated Mortaility Rate
Discharge Blood Pressure (Measurement closest to discharge)
DISCHARGE DIAGNOSIS
ICD-9-CM Discharge Diagnosis related to stroke
ICD-9 discharge diagnosis related to stroke
No Stroke or TIA Related ICD-9 Code Present
DISCHARGE TREATMENTS
Antithrombotic medication prescribed at hospital discharge
Full dose LMW heparin (Enoxaparin, Others)
If no, documented reasons for no antithrombotic therapy at discharge
Documented reason for not prescribing antithrombotic medication at discharge
Persistent or Paroxysmal Atrial Fibrillation/Flutter
Atrial or paroxysmal fibrillation/flutter during this admission?
If atrial fib/flutter or history of PAF documented, was patient discharged on
Anticoagulation medication prescribed at hospital discharge?
If NC, documented reasons for no anticoagulation
Documented reason for not prescribing anticoagulation therapy at discharge
Antihypertensive medication prescribed at hospital discharge
Cholesterol reducing/controlling treatment
Documented reason for not prescribing a statin medication at discharge?
Documented reason for not prescribing statins at discharge
Documentation that the patient has evidence of atherosclerosis?
Patient/Caregiver was given smoking cessation advice or counseling during the hospital stay
X=Needs to be bolded in the CRJC=Only in Joint Commission Overlay#=Outcome needs to add to Coverdell Overlay
Effective for discharges 10/1/10 and later
@=Abstract for cases discharged prior to 10/1/10
GWTG Stroke PMT (Standard and Coverdell) Crosswalk with MSRT PMT Data Element Name MSRT Data Element Name OTHER LIFESTYLE INTERVENTIONS
Reducing weight and/or increasing activity recommendations
STROKE EDUCATION
Personable Modifiable Risk Factors for Stroke
STROKE REHABILITATION
Patient was assessed for and/ or received rehabilitation services?
Patient received rehabilitation services during hospitalization
Patient received rehab services during hospitalization
Patient transferred to rehabilitation facility
Patient referred to rehabilitation services following discharge
Patient ineligible to receive rehabilitation services because symptoms resolved
Patient ineligible to receive rehab services
Patient ineligible to receive rehabilitation services due to impairment (i.e., poor
Patient ineligible to receive rehab services
prognosis, patient unable to tolerate rehabilitation therapeutic regimen)
OPTIONAL FIELDS
PMT used concurrently or retrospectively or combination?
Was a stroke admission order set used in this patient?
Was a stroke discharge checklist used in this patient?
ARRIVAL INFORMATION
What is the patient's source of payment for this episode of care?
X=Needs to be bolded in the CRJC=Only in Joint Commission Overlay#=Outcome needs to add to Coverdell Overlay
Effective for discharges 10/1/10 and later
@=Abstract for cases discharged prior to 10/1/10
GWTG Stroke PMT (Standard and Coverdell) Crosswalk with MSRT PMT Data Element Name MSRT Data Element Name PSC OPTIONAL FIELDS
Date/Time neurosurgical services consulted
CODING KEY VARIABLES IV THROMBOLYTIC THERAPY Contrandications
SBP > 185 or DBP > 110 mmHg despite treatment
Recent intracranial or spinal surgery, head trauma, or stroke (<3 mo.)
History of intracranial hemorrhage or brain aneurysm or vascular malformation or
Platelets <100,000, PTT> 40 sec after heparin use, or PT > 15 or INR > 1.7, or
Warnings
Care-team unable to determine eligibility
X=Needs to be bolded in the CRJC=Only in Joint Commission Overlay#=Outcome needs to add to Coverdell Overlay
Effective for discharges 10/1/10 and later
@=Abstract for cases discharged prior to 10/1/10
GWTG Stroke PMT (Standard and Coverdell) Crosswalk with MSRT PMT Data Element Name MSRT Data Element Name
Increased risk of bleeding due to comorbid conditions
Life expectancy < 1 year or severe co-morbid illness or CMO on admission
Additional Warnings
Prior stroke and presence or history of diabetes
Any anticoagulant use prior to admission (even if INR < 1.7)
CT findings of stroke involving more than 1/3 of middle carotid artery
MSRT ONLY FIELDS
Was patient placed on observation status or in an observation unit at this hospital?
If not admitted to this hospital, where was patient transferred/released?
X=Needs to be bolded in the CRJC=Only in Joint Commission Overlay#=Outcome needs to add to Coverdell Overlay
Effective for discharges 10/1/10 and later
@=Abstract for cases discharged prior to 10/1/10
MANDATORY COUNTRY OF ORIGIN LABELING—INTERIM FINAL RULE For Meat, Perishable Agricultural Commodities, Peanuts, Macadamia Nuts, Pecans, and Ginseng Implementation Timeframes The interim final rule will become effective September 30, 2008, as directed by the statute. The requirements of this rule do not apply to covered commodities produced or packaged before September 30, 2008. Beca
CANDIDA QUESTIONNAIRE The total score will help you and your naturopath decide if your health problems are yeast-connected. Scores in women will run higher, as seven items in the questionnaire apply exclusively to women, while only two apply exclusively to men. ** Women with scores over 130 and men with scores over 140. Yeast connected health problems almost a certainty. ** Women with s